ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

May 19, 1995

Eight States Get Cervical Cancer Screening Planning Contracts

June 21, 1974

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

Clinton Budget Proposes Increase For AIDS, tuberculosis, In FY94

April 23, 1993

NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.

March 18, 2005

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014